# Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts

> **NCT00804050** · PHASE3 · TERMINATED · sponsor: **Fondazione Italiana Sindromi Mielodisplastiche-ETS** · enrollment: 184 (estimated)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** infusion A: rEPO
- **DRUG:** B Infusion rEPO combined with vitamins pills

## Key facts

- **NCT ID:** NCT00804050
- **Lead sponsor:** Fondazione Italiana Sindromi Mielodisplastiche-ETS
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2009-03
- **Final completion:** 2010-03
- **Target enrollment:** 184 (ESTIMATED)
- **Why stopped:** Difficulties of enrollment
- **Last updated:** 2011-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00804050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00804050, "Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00804050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*